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Introduction
Mitosis is a fundamental, regulated cellular process responsible 
for the generation of a mitotic spindle with two spindle poles, and 
daughter cells. Disrupted mitosis often leads to daughter cells 
with aberrant spindle poles and cellular pathogenesis (Sankaran 
and Parvin, 2006). Entry and progression through mitosis is   
a tightly regulated dynamic process involving activation of 
multiple kinases, including Aurora A (Marumoto et al., 2005). 
Association of Aurora A with centrosomes, spindle poles, aster 
microtubules, and the midbody supports its role in regulating 
centrosome maturation, duplication, and cell cycle progression, 
all of which are often compromised and dysregulated in the ab-
sence of Aurora A (Katayama et al., 2003). Loss of Aurora A in 
embryonic mice is lethal due to defects in mitotic spindle assem-
bly and misaligned and lagging chromosomes (Sasai et al., 2008). 
In contrast, Aurora A up-regulation promotes centrosome ampli-
fication, aneuploidy, and cancer, and Aurora kinase expression is 
often elevated in many cancer types (Katayama et al., 2003). The 
paramount role of Aurora A in the biology of both normal and 
cancer cells has led to increasing interest in the molecular mecha-
nisms responsible for Aurora A activation.
A number of Aurora A activators and substrates have been 
identified. For example, LATS2 and NDEL1 are Aurora A   
substrates that affect centrosome maturation, and Aurora A– 
mediated phosphorylation of TACC helps stabilize aster micro-
tubules (Barros et al., 2005; Abe et al., 2006; Mori et al., 2007). 
Aurora A also phosphorylates tumor suppressors BRCA1 and 
p53  and  influences  their  function  in  cell  cycle  progression   
(Katayama et al., 2004; Ouchi et al., 2004). Upstream activators 
of Aurora A, such as Ajuba in humans and Bora in Drosophila, 
participate  in  centrosome  maturation  (Hirota  et  al.,  2003;   
Hutterer et al., 2006). The cofactor TPX2 targets Aurora A to 
mitotic  spindle  microtubules  and  plays  an  important  role  in 
spindle assembly in humans and in Xenopus (Bayliss et al., 2003).   
Aurora A activities and functions are also regulated by cytoskel-
eton remodeling components such as p21-activated kinase 1 
(Pak1; Zhao et al., 2005), integrin-linked kinase (Fielding et al., 
2008), the focal adhesion scaffolding factor Hef1 (Pugacheva 
and Golemis, 2005; Wu et al., 2006), and Rho GTPases (Ando 
et al., 2007), but the role of the actin cytoskeleton in Aurora A 
biology remains unknown.
H
ere we provide evidence in support of an inherent 
role for Arpc1b, a component of the Arp2/3 com-
plex, in regulation of mitosis and demonstrate that 
its depletion inhibits Aurora A activation at the centrosome 
and impairs the ability of mammalian cells to enter mitosis. 
We discovered that Arpc1b colocalizes with -tubulin at 
centrosomes and stimulates Aurora A activity. Aurora A 
phosphorylates Arpc1b on threonine 21, and expression of 
Arpc1b but not a nonphosphorylatable Arpc1b mutant in 
mammalian cells leads to Aurora A kinase activation and 
abnormal centrosome amplification in a Pak1-independent 
manner. Together, these findings reveal a new function for 
Arpc1b in centrosomal homeostasis. Arpc1b is both a 
physiological activator and substrate of Aurora A kinase 
and these interactions help to maintain mitotic integrity in 
mammalian cells.
Arpc1b, a centrosomal protein, is both an activator 
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Figure 1.  Arpc1b interacts with Aurora kinase A. (A) ZR-75 cells synchronized by double-thymidine block and released for 6 h were analyzed for centro-
some numbers. -Tubulin (green) is used to indicate spindle morphology and pericentrin (red) is used to indicate centrosomes. DNA is in blue. N, number 
of centrosomes per cell. Quantitation for the centrosome numbers in the different stable cell lines generated in ZR-75 cells is shown below panel A. Bar, 20 µm. 
(B) ZR-75 cell lysates were incubated with either GST or GST-Arpc1b and the protein complex precipitated was subjected to Western blot analysis with 
the antibodies. Ponceau-stained blot shows the quality of GST proteins used for the study. (C) GST control or GST-Aurora A was incubated with purified 
Arp2/3 complex and the immunoprecipitates were subjected to Western blot analysis using an anti-Arpc1b or anti-Arpc2 antibody. (D) ZR-75 cell extracts 
were fractionated onto 3–30% sucrose gradients by velocity sedimentation, and then subjected to Western blot analysis with the indicated antibodies.   103 Bidirectional regulation of Arpc1b–Aurora A pathway • Molli et al.
Arpc1b up-regulation conferred a growth advantage to ZR-75 
cells in anchorage-independent growth (Fig. S1 B) and tumori-
genesis assays (Fig. S1, C and D). Interestingly, tumors in all 
seven mice with Arpc1b-overexpressing cells displayed a higher 
frequency of cells with multiple centrosomes whereas only one 
of seven mice with pcDNA developed a tumor, as assessed by 
anti-centrin antibodies (Fig. S1 E). Centrosomal amplification in 
tumors is intimately linked with stimulation of Aurora A kinase. 
We found elevated levels of activated Aurora A in mouse tumors 
isolated from ZR-75/Arpc1b compared with ZR-75/pcDNA cells, 
as revealed by immunohistochemical analysis with an anti– 
phospho-Aurora A  (Thr288)  antibody  (unpublished  data). 
These observations suggest that Arpc1b overexpression, which 
is a physiologically relevant event in human breast cancer, 
promotes tumorigenic properties of breast cancer cells. Subse-
quently, the ZR-75 cell line was used to specifically examine 
the role of Arpc1b in mitosis.
Arpc1b is an Aurora A–interacting protein 
that localizes to centrosomes
To explore the role of Arpc1b in mitosis, we initially used ZR-75 
breast cancer cells overexpressing Arpc1b as a model system to 
study centrosome duplication, a hallmark of normal cell cycle 
regulation. Arpc1b overexpression was accompanied by centro-
some amplification (Fig. 1 A), suggesting that Arpc1b helps de-
termine the cellular integrity of the centrosome. Because Aurora 
kinases, particularly Aurora A, play an important role in main-
taining spindle integrity and dysregulated activation of Aurora A 
causes centrosome amplification, we examined the possibility 
that Arpc1b interacts with Aurora A. GST-tagged Arpc1b inter-
acted with Aurora A from ZR-75 cell lysates (Fig. 1 B). Because 
Arpc1b is a component of the Arp2/3 complex (Machesky and 
Gould, 1999; Goley and Welch, 2006), we wanted to evaluate 
whether purified Arp2/3 complex also interacts with Aurora A, 
as does GST-Arpc1b. Toward this end, GST-control or GST- 
Aurora A was incubated with purified Arp2/3 complex, and the 
immunoprecipitates  were  subjected  to  Western  blot  analysis   
using an anti-Arpc1b or anti-Arpc2 antibody. In addition to a direct 
interaction with Arpc1b (Fig. 1 B), Aurora A also interacted with 
the Arpc1b and Arpc2 as a part of the Arp2/3 complex (Fig. 1 C). 
To further distinguish the possibility that Arpc1b may also exist 
as a stand-alone protein in addition to acting as a component of 
the Arp2/3 complex, we performed a sucrose gradient sedimen-
tation experiment using ZR-75 cell extracts following methods 
described previously (Humphries et al., 2002). Arpc1b had two 
distinct peaks (fractions 6–9 and 12–15; Fig. 1 D). In contrast, 
the two other components of the Arp2/3 protein complex, Arp3 
and Arpc2 (Machesky and Gould, 1999; Goley and Welch, 2006), 
The actin cytoskeleton undergoes dramatic cell cycle– 
dependent remodeling but its role in mitosis is not very well under-
stood. G-actin is present both in the cytoplasm of interphase cells 
and in the mitotic phase of LLC-PK1 cells, COS, and CHO cells 
(Meijerman et al., 1999). Similarly, nuclear extracts from 293T 
cells contain all of the cofactors required for actin polymeriza-
tion, including actin-related protein 3 (Arp3; Wu et al., 2006). 
Studies on Schizosaccharomyces pombe suggest a defective actin 
cytoskeleton results in a disoriented spindle and delayed cell divi-
sion (Gachet et al., 2001). These observations predict a role for 
the actin cytoskeleton or actin-associated proteins in the regula-
tion of mitosis and perhaps the cell cycle. The Arp2/3 complex is 
an actin regulator that initiates formation of new actin filaments 
(Zigmond, 1998; Goley and Welch, 2006). The complex consists 
of seven subunits known as Arp2, Arp3, Arpc1, Arpc2, Arpc3, 
Arpc4, and Arpc5. Arpc1 has two isoforms in humans, Arpc1a 
and Arpc1b. In earlier studies designed to isolate novel Pak1- 
interacting proteins during mitosis, we screened a complementary 
DNA expression library from mitotic HeLa cells with a GST-
Pak1 solid-phase kinase assay, and identified Arpc1b as a Pak1- 
interacting substrate (Vadlamudi et al., 2004b). Pak1 phosphorylates 
Arpc1b on threonine 21 (T21) in the first repeat, a modification 
required for cell motility in growth factor–stimulated cells. Thus, 
we predict Arpc1b may have a role in mitosis.
Here we provide evidence that Arpc1b localizes on centro-
somes and has a distinct role in cell cycle progression. Arpc1b   
interacts with and stimulates Aurora A activity and participates in 
the progression of the G2/M phase. Surprisingly, we discovered 
that Aurora A kinase phosphorylates Arpc1b on Thr21 and causes 
abnormal centrosome amplification in Pak1-deficient cells. These 
studies describe Arpc1b as a novel centrosome-associated protein 
that is a physiological activator and substrate of Aurora A kinase. 
Interactions of Arpc1b with Aurora A kinase are critical in the 
maintenance of mitotic integrity in mammalian cells.
Results
Arpc1b and tumorigenesis
A  recent  high-resolution  expression  profiling  study  suggested 
that Arpc1b is amplified in human pancreatic cancer cell lines 
(Mahlamäki et al., 2004). Thus, we initially explored whether   
Arpc1b is also up-regulated in human breast tumors using a limited 
number of paired samples. Arpc1b protein was up-regulated in   
8 of 10 human breast tumors (Fig. S1 A). Because Arpc1b is   
dysregulated in human breast tumors, we examined the role of 
Arpc1b overexpression in the biology of ZR-75 breast cancer 
cells using pooled clones overexpressing Arpc1b (ZR-75/Arpc1b) 
or pcDNA empty vector (ZR-75/pcDNA) as model systems.   
(E) GST-tagged deletion mutants of human Aurora kinase A. Aurora A, 1–403 is the full-length protein. In vitro–translated 
35S-labeled Arpc1b was used 
to study binding of different GST-Aurora A deletion mutants. The extent of binding was estimated by measuring signal intensity. Ponceau S staining shows 
equal quantity of GST and GST-Aurora A deletions used in the reaction. Asterisk denotes the GST-fused protein of interest; black arrows indicate the inter-
acting region of Aurora kinase A with Arpc1b. (F) Asynchronized cells or cells blocked with thymidine and released for various time points were used for 
immunoprecipitation (IP). Transfected T7-Arpc1b was immunoprecipitated using T7 antibody and the blot was probed for Aurora A. (G) Asynchronized 
cells or cells blocked with thymidine and released for various time points were subjected to the sequential IP/Western blot with the indicated antibodies. 
(H) Protein extract from ZR-75 cells released for 0 or 8 h after double-thymidine block were subjected to reciprocal immunoprecipitation assays with an 
anti-Aurora A or anti-Arpc1b antibody, followed by Western blot analysis with the indicated antibodies. kD, kilodaltons.
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had only one peak (fractions 12–14 and 11–17, respectively; 
Fig. 1 D). In fact, Arp3 and Arpc2 comigrated with Arpc1b 
only in fractions 12–14 (Fig. 1 D). These results suggest that   
Arpc1b can indeed exist as a stand-alone protein and might play 
an independent role outside its established contribution to the 
Arp2/3 complex. Interestingly, Aurora A was present in frac-
tions containing only Arpc1b (fractions 5–9) as well as those 
containing  both  Arpc1b  and  the  Arp2/3  complex  (fractions   
12–15). These data are consistent with the notion that Aurora A 
interacts not only with Arpc1b alone, but also with the purified 
Arp2/3 complex.
We performed in vitro GST pull-down assays to further 
determine whether a direct interaction between Arpc1b and   
Aurora A occurs. 
35S-labeled, in vitro–translated Arpc1b pro-
tein bound strongly to the N-terminal domain, specifically the   
“A-box III” containing region encompassing amino acids 66–90   
of Aurora A (Fig. 1 E). In cells, Aurora A levels peak during the 
late S phase and remain high during the G2-M phase of the cell 
cycle (Walter et al., 2000; Katayama et al., 2001). To determine 
at what point the interaction between endogenous Aurora A ki-
nase and the transfected T7-tagged Arpc1b occurs, ZR-75 cells 
expressing T7-Arpc1b were arrested in the early S-phase using 
double-thymidine block and released into the cell cycle at vari-
ous time points. The purity of cell synchronization was verified 
by flow cytometry and cyclin A expression (unpublished data). 
T7-tagged  Arpc1b  (T7-Arpc1b)  interacted  with  endogenous 
Aurora A 6–10 h after release from the thymidine block (Fig. 1 F). 
In contrast, T7-Arpc1b was persistently associated with endog-
enous Arp3 at all of the time points (Fig. 1 G). To further exam-
ine whether endogenous levels of Arpc1b and Aurora A proteins 
may interact in a physiological context, ZR-75 cells were sub-
jected to double-thymidine block and then released at the indi-
cated time points. Protein extracts were subjected to the reciprocal 
immunoprecipitation analysis using an anti-Aurora A or anti-
Arpc1b antibody, followed by Western blot analysis with the   
indicated antibodies. Consistent with the above findings, endog-
enous Aurora A and Arpc1b interacted at the 8-h time point 
(Fig. 1 H). Furthermore, when we probed the same membranes 
for vinculin, no bands were seen in the immunoprecipitates, even 
after long exposure (Fig. 1 H, bottom). Taken together, these re-
sults indicate that Arpc1b interacts with Aurora A in a cell cycle–
dependent manner.
As a component of the Arp2/3 complex, Arpc1b primarily 
resides in the cytoplasm. However, a small amount of Arpc1b 
was reproducibly detected at the centrosome. Thus, we studied 
the subcellular localization of endogenous Arpc1b during the 
cell cycle after thymidine block. The majority of Arpc1b was 
cytoplasmic with a small fraction associated with the centro-
some. A detailed confocal microscopic analysis indicated that 
endogenous Arpc1b colocalized with the centrosomal markers 
Aurora A and -tubulin (Fig. 2 A), and ectopic GFP-Arpc1b 
(Fig. S2) colocalized with -tubulin. Centrosomal staining of 
Arpc1b was confirmed using siRNA to Arpc1b, which led to the 
disappearance of Arpc1b staining at the centrosome with no   
effect on staining for Aurora A and -tubulin (Fig. S3 B). The 
specificity of Arpc1b knockdown was verified by probing for 
Arpc2, Arp3, and Aurora A as controls (Fig. S3 A). In support 
Figure  2.  Arpc1b  localizes  to  the  centrosome.  (A)  Synchronized  ZR-75 
cells  were  released  for  6  h  and  analyzed  for  endogenous  Arpc1b   
colocalization with centrosomal proteins Aurora A and -tubulin. Aurora A   
and  -tubulin  (green);  endogenous  Arpc1b  (red);  DNA  (blue).  Circle 
marks centrosome location. Bar, 5 µm. (B) Equal amount of cell extract 
was immunoprecipitated with control IgG or -tubulin antibody from the 
synchronized cells (top panel). The same blot was probed for Arpc1b 
(second last panel) and Arp3 (last panel). The blot was stripped and 
probed for Aurora A (second panel). (C) Equal amount of cell extract was 
immunoprecipitated with control IgG or Aurora A antibody (top panel). 
The same blot was probed for -tubulin (second panel) and Arp3 (last 
panel). Input, cell lysate used as positive control. (D) Xenopus egg extract 
was treated with either GST (control) or GST-WASP-CA (Arp3 depletion) 
and used for IP experiments. The Western blot shows Arp3 depletion 
in GST-WASP-CA–treated egg extract (top panel) and the GST-Aprc1b 
(second panel) used for the study. Aurora A was immunoprecipitated 
from the treated egg extract and incubated with GST-Arpc1b protein. 
The Western blot shows immunoprecipitated Aurora A and GST-Arpc1b 
or endogenous Arpc1b in complex with Aurora A in control and Arp3-
depleted egg extract. (E) Aurora A was immunoprecipitated from the 
treated egg extract. Western blot shows immunoprecipitated Aurora A 
and endogenous Arpc1b in complex with Aurora A in control and Arp3-
depleted egg extract. kD, kilodaltons.105 Bidirectional regulation of Arpc1b–Aurora A pathway • Molli et al.
of Arpc1b with Aurora A. There was no difference in the inter-
action of GST-Arpc1b or endogenous Arpc1b with Aurora A 
in control, GST-treated, or Arp3-depleted GST-N WASP-CA–
treated extracts (Fig. 2 D). When a similar experiment was 
performed without adding exogenous GST-Arpc1b, the inter-
action between endogenous Arpc1b and Aurora A was im-
proved (Fig. 2 E). These results, shown in Fig. 2, D and E, 
suggest  that  GST-Arpc1b  added  to  the  oocyte  extract  may 
compete with endogenous Arpc1b for binding to Aurora A. 
Alternatively, Arp3 depletion may destabilize the Arp2/3 com-
plex. These findings collectively indicate that the interaction 
with Aurora A is specific to Arpc1b and independent of the 
Arp2/3 complex.
of these results, we found that -tubulin coimmunoprecipitated 
with endogenous Arpc1b and Aurora A but not Arp3 from 
ZR-75 cells arrested in the metaphase (Fig. 2 B). Furthermore, 
immunoprecipitation using an anti-Aurora A antibody failed to 
immunoprecipitate Arp3 (Fig. 2 C).
The above results indicate two possibilities. Either the 
Arp2/3 complex fell apart during immunoprecipitation and, 
therefore, we did not observe Arp3 in the complex with either 
-tubulin or Aurora A, or the fraction of Arpc1b that exists in-
dependently of the Arp2/3 complex in cells was able to associ-
ate with Aurora A. To address these possibilities,  Xenopus 
oocyte extracts were immunodepleted of Arp3 using GST-N 
WASP-CA (Yang et al., 2000) and used to study interactions 
Figure  3.  Arpc1b  stimulates  activity  of  Au-
rora  A.  (A)  GST  alone  or  GST-Arpc1b  was 
used  in  an  in  vitro  kinase  assay  with  GST-
Aurora A or GST-Aurora A KD protein. Phos-
phorylated  histone  H3  was  visualized  by 
autoradiography. Ponceau-stained blot shows 
equal  amount  of  histone  H3  used  for  both 
reactions. Western blot shows equal amount 
of  Aurora  A  was  used  in  all  the  reactions. 
(B) GST, GST-Arpc1b, or GST-Arp3 was used 
in an in vitro kinase assay with recombinant 
Aurora  A  using  Histone  H3  as  a  substrate. 
Phosphorylated histone H3 was visualized by 
autoradiography (top panel). Ponceau-stained 
blot shows equal amount of GST proteins and 
histone H3 used for all the reactions. Asterisk 
denotes  the  GST-fused  protein  of  interest.   
(C) Aurora A kinase activity was studied using 
histone H3 as a substrate in the presence or 
absence purified Arp2/3 complex. Ponceau-
stained  blot  shows  equal  amount  of  histone 
H3 and the Western blot shows equal amount 
of Aurora A used in the reactions. (D) GST or 
GST-Arpc1b was incubated with phosphatase 
(PP1)-treated  Aurora  A  for  20  min  in  pres-
ence of [
32P]ATP. Samples were analyzed for   
Aurora A phosphorylation (Thr-288, top panel) 
and total Aurora A (last panel). Fold change 
was expressed with respect to lane 1. (E) ZR-75   
cells  transfected  with  either  control  siRNA   
or Arpc1b siRNA were subjected to in vivo 
32P-
labeling. Protein extracts were subjected to IP 
with an anti-Aurora A antibody, and phosphor-
ylated Aurora A was visualized by autoradi-
ography. Knockdown of Arpc1b was verified 
by Western blot with an anti-Arpc1b antibody 
(bottom panel). (F) Immunoblots showing levels 
of phospho-Aurora A (Thr288), phospho-plk1 
(Thr 210), and phospho-histone H3 (Ser 10) in 
control and Arpc1b siRNA-treated ZR-75 cell 
lysates. kD, kilodaltons.JCB • VOLUME 190 • NUMBER 1 • 2010   106
Figure 4.  Arpc1b is essential for progression to G2-M phase of cell cycle. (A) Synchronized ZR-75 cells transfected with control, Arpc1b, or Arp3 siRNA 
and released for 7 h after G1-S arrest were immunostained with antibodies to Aurora A (green) or phospho-Aurora A T288 (red) as indicated. Insets 
represent higher magnification images of centrosomes. Bar plot shows percentage of cells with Aurora A–positive centrosomes (B), and distribution of 
phospho-Aurora A on centrosomes (C) on transfecting ZR-75 cells with control, Arpc1b, or Arp3 siRNA. Staining for phospho-Aurora A on both centro-
somes: arrowheads in bar graph = absent from both centrosomes; diagonal lines = present on only one centrosome; black = reduced staining for both 
centrosomes. Bar, 5 µm. (D) ZR-75 cells were transfected with control siRNAs, or specific siRNAs targeting Arpc1b, Arp3, Arpc1a, or Aurora A, and 
protein extracts were subjected to Western blot analysis with the indicated antibodies. (E and G) Synchronized ZR-75 cells transfected with control or   107 Bidirectional regulation of Arpc1b–Aurora A pathway • Molli et al.
Arpc1b is required for optimal cell  
cycle progression
To determine the significance of Arpc1b during mitosis, we com-
bined cell synchronization with siRNA silencing. ZR-75 cells 
were transfected with either control or Arpc1b siRNA or siRNA 
to two other components of the Arp2/3 complex, Arp3 and   
Arpc1a, in the interval between the two thymidine blocks. Cells 
transfected with Arpc1b-siRNA#1 (Fig. 4 A) or another Arpc1b-
siRNA#2 (Fig. S4 B) were subjected to immunofluorescence 
analysis with antibodies against Aurora A and phospho-Aurora A 
(Thr288). Although Aurora A localized to the centrosome in cells 
transfected with Arpc1b siRNA, only 50% of cells displayed 
Aurora A activation, and Aurora A remained active either on only 
one centrosome or was inactive on both centrosomes (Fig. 4,   
A–C; and Fig. S4 B). In contrast to Arpc1b knockdown, siRNA 
of controls/Arp3 (Fig. 4, A–C) and Arpc1a (Fig. S4 C) had no   
effect on Aurora A activation on the centrosome.
We also studied the effect of Arp2/3 complex knockdown 
on cell cycle progression. Depletion of Arpc1b but not Arpc1a 
or Arp3 drastically reduced the ability of cells to enter the G2/M 
phase of the cell cycle (Fig. 4 E). Knockdown effects of Arpc1b, 
Arpc1a, and Arp3 siRNAs were demonstrated by Western blot 
analysis with the indicated antibodies (Fig. 4 D). To confirm the 
role of Arpc1b in regulating progression to mitosis, we assessed 
the number of mitotic, phospho-H3–positive cells in control and 
Arpc1b-depleted samples. Knockdown of Arpc1b drastically 
reduced the phosho-H3–positive cells compared with control 
siRNA-treated samples (Fig. 4 F).
Given the evidence that Arpc1b depletion is responsible 
for decreased Aurora A activation (Fig. 3, E and F), we examined 
whether this negative effect was responsible for delayed mitotic 
entry or whether the low Aurora A activity is a consequence of 
blocked cell cycle progression. We used specific siRNAs target-
ing human Aurora A to knockdown endogenous Aurora A in   
ZR-75 cells, demonstrated by Western blot in Fig. 4 D (bottom 
right panel), and analyzed the cell cycle as described in Fig. 4,   
E and F. Aurora A knockdown significantly reduced cells in the 
G2/M phase (Fig. 4 G). This was further validated by phospho-
histone H3 staining of control and Aurora A siRNA-transfected 
cells after thymidine release (Fig. 4 H). Thus, knockdown of 
Aurora A clearly compromised progression of cells in the G2/M 
phase, similar to the results shown in Fig. 4, E and F. These   
results indicate that the negative effect of Arpc1b depletion on 
Aurora A activity could be responsible for delayed mitotic entry 
in Arpc1b-depleted cells.
To further support these observations, we performed a mo-
lecular replacement experiment using an Arpc1b-T21A mutant 
that was able to function as a component of the Arp2/3 complex 
but unable to interact with or activate Aurora A. We performed 
the same experiments described in Fig. 4, E and F using stable 
It was also of interest to investigate the previously observed 
interaction of Arpc1b with -tubulin. To accomplish this, we 
probed the same membranes from the sucrose density gradient 
experiments (Fig. 1 D) with a monoclonal anti–-tubulin anti-
body to determine the distribution of -tubulin on the sucrose 
density gradient based on the sedimentation profile. Similar stud-
ies from other laboratories have demonstrated that complexes of 
interacting proteins cofractionate on a sucrose density gradient 
after sedimentation (Ma et al., 1998). The results showed that   
-tubulin and Arpc1b coexisted in fractions 12–15 (Fig. 1 D, 
bottom). More interestingly, we also detected -tubulin in frac-
tions 6–9, which represents the Arpc1b-only complex. Taken   
together,  these  experiments  provide  additional  biochemical 
evidence to support the possibility that Arpc1b interacts with   
-tubulin, and the presence and physiological relevance of   
-tubulin in Arpc1b-only fractions warrant further investigation.
Arpc1b activates Aurora A
Because Arpc1b interacts with Aurora A and also localizes to 
centrosomes, we determined whether Arpc1b may activate   
Aurora A kinase. In an in vitro kinase assay using histone H3 as a 
substrate, Arpc1b enhanced Aurora A kinase activity (Fig. 3 A).
Kinase-dead Aurora A was used as a negative control. Interest-
ingly, neither Arp3 (Fig. 3 B) nor Arpc1a (Fig. S4 A), another two 
subunits of Arp2/3 complex (Machesky and Gould, 1999; Goley 
and Welch, 2006), enhanced the kinase activity of Aurora A, 
whereas the purified Arp2/3 complex did (Fig. 3 C). The observed 
effect of the Arp2/3 complex on Aurora A activity could be due, 
at least in part, to the presence of Arpc1b in the Arp2/3 complex.
Because Aurora A is phosphorylated in its activation loop 
at Thr288 (T288), presumably due to auto-phosphorylation 
(Littlepage et al., 2002), we investigated the significance of   
Arpc1b to Aurora A phosphorylation at this site. Treatment of 
Aurora A with purified type-1 protein phosphatase (PP1) re-
duced Aurora A kinase activity, and this decrease in activity cor-
responded  to  de-phosphorylation  of  T288,  as  detected  by 
phospho-site–specific immunoblotting (Fig. 3 D). Adding GST-
Arpc1b increased kinase activity of Aurora A with a correspond-
ing increase in T288 phosphorylation (Fig. 3 D, lane 5) compared 
with a GST control (Fig. 3 D, lane 4). To further validate the role 
of Arpc1b in Aurora A activation, ZR-75 cells were transfected 
with specific siRNAs that target human Arpc1b or control 
siRNAs,  and Aurora A  phosphorylation  was  examined  after   
32P-labeling. Interestingly, knockdown of Arpc1b led to a decrease 
in Aurora A phosphorylation in situ (Fig. 3 E) as well as phos-
phorylation of its well-established downstream effectors, such as 
polo-like kinase 1 (plk-1; Macůrek et al., 2008) and histone H3 
(Scrittori et al., 2001; Crosio et al., 2002; Fig. 3 F). Taken to-
gether, these findings suggest that Arpc1b is an interacting acti-
vator of Aurora A kinase.
specific siRNAs targeting Arpc1b, Arpc1a, or Arp3 (E) or Aurora A (G) were scored for percentage of cells in G2-M phase at the indicated time points 
after release from G1-S arrest using FACS analysis; n = 3. (F and H) Synchronized ZR-75 cells transfected with either control or Arpc1b siRNA (F) or Aurora A   
siRNA (H) were scored for percentage of phospho-H3–positive cells at the indicated time points after release from G1-S arrest using FACS analysis;   
n = 3. (I and J) Synchronized ZR-75 cells stably expressing wild-type Arpc1b (ZR-75/T7-Arpc1b) or Arpc1bT21A (ZR-75/T7-Arpc1b T21A) were scored 
for percentage of cells in G2-M phase (I) or for percentage of phospho-H3–positive cells (J) at the indicated time points after release from G1-S arrest using 
FACS analysis; n = 3. kD, kilodaltons.
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cycle progression are specific to the knockdown of Arpc1b and 
that Arpc1b facilitates activation of Aurora A at centrosomes and 
regulates the progression of cells into mitosis.
Arpc1b-T21A mutant lacks the ability to 
bind and activate Aurora A
Because overexpression of Pak1 (Vadlamudi and Kumar, 2003; 
Kumar et al., 2006) or its substrate Arpc1b (Fig. 1 A) resulted in 
an accumulation of centrosomes, we hypothesized that Arpc1b 
clones of ZR-75 cells expressing T7-tagged wild-type Arpc1b 
(ZR-75/T7-Arpc1b) or the T7-Arpc1b-T21A mutation (ZR-75/
T7-Arpc1b-T21A). As shown in Fig. 4, I and J, in contrast to 
wild-type  controls, Arpc1b-T21A  mutants  exhibited  compro-
mised cell cycle progression and mitosis. These results suggest 
that the observed defects in cell cycle progression in Arpc1b-
T21A–expressing cells may have resulted due to an inability to 
bind and activate Aurora A. Taken together, these findings sug-
gest that the defects observed in Aurora A activation and cell   
Figure 5.  Phosphorylation of Arpc1b on Thr 21 regulates centrosome numbers in ZR-75 cells. (A) Expression of T7-Arpc1b (top) and endogenous Arpc1b 
(bottom) in stable cell lines generated in ZR-75 cells for indicated point mutations of Arpc1b. Quantitation for the centrosome numbers in the different 
stable cell lines generated in ZR-75 cells are shown below panel A. Synchronized cells released for 6 h after G1-S arrest were used for immunostaining. 
Representative images showing the distribution of -tubulin (green, B); Aurora A (green, C), and DNA (blue) in the stable cell lines. -Tubulin was used as 
a centrosome marker. Bars, 5 µm. (D) Synchronized cells released for 7 h after G1-S arrest were subjected to immunoprecipitation using agarose-tagged 
Aurora A antibody. The resulting precipitates were used for an in vitro kinase assay with histone H3 as substrate. Autoradiograph shows Aurora A, phos-
phorylated histone H3, and total histone H3. (E) 
32P-labeled ZR-75 cells expressing either T7-Arpc1b or T7-Arpc1bT21A were treated with 100 ng/ml of 
EGF for 5 min. Arpc1b was immunoprecipitated using an anti-T7 antibody (second panel) and the in vivo phosphorylation of Arpc1b was analyzed using 
autoradiography (first panel). The same blot was probed for Aurora A (third panel). WT, wild type; kD, kilodaltons.109 Bidirectional regulation of Arpc1b–Aurora A pathway • Molli et al.
phenotypic changes in cells expressing T7-Arpc1b-T21A, which 
indicates a mechanistic role of the T21 site on Arpc1b function 
in the development of these phenotypes. To identify biochemi-
cal differences in the spindle phenotype observed in cells ex-
pressing T7-Arpc1b-WT or T7-Arpc1b-T21A, we determined 
the status of Aurora A activity in these stable cell lines. Cells 
expressing T7-Arpc1b-T21A had less Aurora A activity (40%) 
than did T7-Arpc1b or T7-Arpc1b-T21E cells (Fig. 5 D). Fur-
thermore, Aurora A was pulled down in the complex with only 
Arpc1b in response to EGF, a known stimulant for Pak kinase 
may be a downstream effector of Pak1-mediated aberrant spin-
dle formation. We addressed this by determining the effect of 
Arpc1b-T21 mutants on Aurora A activation and cell cycle   
progression. We generated pooled ZR-75 clones expressing a   
phosphorylation-defective T7-tagged Arpc1b-T21-Ala mutant 
(Arpc1b-T21A) or a phospho-mimetic mutant Arpc1b-T21-Glu 
(Arpc1bT21E; Fig. 5 A). Cells expressing T7-Aprc1b-WT   
or Arpc1b-T21E exhibited centrosome amplification, as indi-
cated by an increased number of -tubulin (Fig. 5 B) and   
Aurora A foci (Fig. 5 C). Interestingly, we failed to observe such 
Figure  6.  Phosphorylation  of  Arpc1b  on   
Thr 21 regulates its interaction with Aurora A. 
(A)  In  vitro–translated 
35S-labeled  Aurora  A 
was used to study its binding with GST, GST-
Arpc1b, or GST-Arpc1b T21A. The extent of 
binding  was  estimated  by  measuring  signal 
intensity.  Ponceau-stained  blot  shows  equal 
quantity  of  GST-tagged  proteins  used  for 
each reaction. (B) GST, GST-Arpc1b, and GST-
Arpc1b T21A were used in an in vitro kinase 
assay  with  recombinant  Aurora  A  protein. 
Phosphorylated histone H3 was visualized by 
autoradiography. Ponceau-stained blot shows 
equal amount of histone H3 and GST-tagged   
proteins used for the study. Circle marks GST-
fused protein of interest. (C) The 1C1 mono-
clonal antibody to Xenopus Aurora A (Eg2) was 
used to immunoprecipitate Eg2 from CSF egg 
extract supplemented with GST control, GST-
TPX2  (1–126),  GST-Arpc1b,  or  GST-Arpc1b 
T21A and the bound proteins were analyzed 
by Western blotting using anti-GST antibodies. 
Asterisk denotes the GST-fused protein of in-
terest. Bar plot shows fold change quantitated 
from three experiments. (D) A phospho-specific 
antibody that recognizes phospho-Thr 295 of 
Eg2 was used to study the extent of activation 
of Aurora A (top panel). Bottom panel shows 
equal amount of Aurora A used in all the reac-
tions. Bar plot shows fold change quantitated 
from three experiments. kD, kilodaltons.JCB • VOLUME 190 • NUMBER 1 • 2010   110
Aurora A is an Arpc1b kinase
Upon analyzing the amino acid sequence of Arpc1b, we identi-
fied T21 as a potential Aurora A kinase phosphorylation site with 
the sequence R/K/N-R-X-S/T-B, where B is any hydrophobic 
(Menard and Mattingly, 2003), whereas Arpc1b-T21A failed to 
do so (Fig. 5 E).
Consistent with the above findings, the direct interaction 
of Aurora A with GST-Arpc1b-T21A was substantially lower 
than that of wild-type Arpc1b (Fig. 6 A). GST-Arpc1b-T21A 
was less able to activate Aurora A (1.01-fold) than was GST-
Arpc1b (1.9-fold; Fig. 6 B). The Arp complex has an impor-
tant  function  in  the  interphase  cytoskeleton.  The  spindle 
defects observed in ZR-75 cells overexpressing Arpc1b could 
be  an  indirect  effect  of  perturbing  interphase  cytoskeletal 
functions. To determine whether Arpc1b has a direct role in 
Aurora A activation and centrosome function, we turned to 
mitotic phase Xenopus oocyte extracts and compared the rel-
ative activation of Aurora A by wild-type Arpc1b versus the 
positive  control,  the  N-terminal  domain  of  Xenopus  TPX2 
(amino acids 1–126), which binds and activates Aurora A 
(Bayliss et al., 2003). In these assays, we measured the activa-
tion of Xenopus Aurora A (Eg2) using phospho-peptide anti-
bodies (P-Eg2) specific for the region of Eg2 that includes 
T295, which is equivalent to T288 in human Aurora A kinase 
(Tsai et al., 2003). Although GST-Arpc1b showed stronger 
binding to Xenopus Aurora A (Fig. 6 C) compared with TPX2, 
both TPX2 and Arpc1b comparably activated Aurora A (Fig. 6 D). 
Similar to that reported for binding inefficiency, GST-Arpc1b-
T21A also exhibited reduced activation of Aurora A compared 
with that of wild-type Arpc1b or TPX2 (Fig. 6, C and D).   
Together, these findings suggest an inherent role of Arpc1b-T21 
phosphorylation in binding and activating Aurora A and that 
the Arpc1b–Aurora A pathway is involved in maintaining spin-
dle organization.
Arpc1b supports centrosome amplification 
in the absence of Pak1
Because Aurora A can be activated by Pak1 (Zhao et al., 2005) 
and Arpc1b, as demonstrated in this study, we determined the 
significance of Pak1 in Arpc1b-mediated centrosome ampli-
fication by using Pak1-knockout (Pak1
/) or wild-type (Pak1
+/+) 
mouse embryonic fibroblasts (MEFs). Depletion of Pak1 was 
accompanied  by  some  compensatory  effects  on  Pak2  and 
Pak3  expression  (Fig.  7  A).  We  generated  stable  pooled   
MEF clones expressing T7-Arpc1b, T7-Arpc1b-T21A, or T7-
Arpc1b-T21E (Fig. 7 B). Pak1
+/+/Arpc1b and Pak1
//Arpc1b-
T21E  displayed  multiple  centrosomes,  whereas  Pak1
+/+/ 
Arpc1b-T21A exhibited normal centrosome numbers (Fig. 7 C). 
Surprisingly, Pak1
/ MEFs overexpressing wild-type Arpc1b 
also displayed an increased number of centrosomes (Fig. 7 D). 
These findings suggest that Arpc1b expression alone, but not 
Arpc1b-T21A, may lead to abnormal centrosome amplifica-
tion and is independent of Pak1 status. We hypothesize that 
the T21 site in Arpc1b is a critical regulator of its functions in 
the  maintenance  of  centrosomal  amplification.  Our  studies 
also indicate that this site on Arpc1b can be regulated by cel-
lular kinases other than Pak1. We studied Arpc1b phosphory-
lation  by  Pak2  and  Pak3  (Fig.  S5).  Both  Pak2  and  Pak3 
phosphorylated Arpc1b on sites other than Thr 21. This sug-
gests that the T21 site on Arpc1b is specific to Pak1 protein 
and not other Pak kinases.
Figure  7.  Role of Pak1 in Arpc1b-mediated centrosome amplification.  
(A) Western blot analysis showing expression of different Pak isoforms in 
the Pak1
+/+ or Pak1
/ MEFs. Vinculin was used as an internal control.   
(B) Western blot analysis showing expression of T7-Arpc1b and endogenous 
Arpc1b levels in stable cell lines generated in the Pak1
+/+ or Pak1
/ MEFs 
for indicated point mutations of Arpc1b. Actin was used as an internal con-
trol. Quantitation of the centrosome numbers in the different stable cell lines 
generated in the Pak1
+/+ or Pak1
/ MEFs cells are shown below panel B. 
(C and D) Representative images showing distribution of -tubulin (green) 
and DNA (blue) in the stable cell lines. -Tubulin was used as a centrosome 
marker. Circle marks centrosome location. Bar, 5 µm. kD, kilodaltons.111 Bidirectional regulation of Arpc1b–Aurora A pathway • Molli et al.
to interact with Arpc2 in the absence of Pak1, but these interactions 
were drastically reduced upon knockdown of Aurora kinase A 
(Fig. 8 C). To further confirm these findings, we knocked down 
Aurora A in the Pak1
/ MEFs and then performed a reverse   
immunoprecipitation assay with an anti-Arpc2 antibody, followed 
by Western blot analysis with an anti-Arpc1b antibody. Consis-
tent with our previous results, knockdown of Aurora A resulted 
in the dissociation of Arp2/3 complex (Fig. 8 D). Together, these 
findings reveal that Arpc1b-T21 phosphorylation by Aurora A or 
by other kinases such as Pak1 modulates its ability to interact 
with other components of the Arp2/3 complex.
amino acid but proline. To test this possibility, we examined the 
ability of purified Aurora A to phosphorylate GST-Arpc1b or the 
GST-Arpc1b-T21A mutant. Aurora A phosphorylated Arpc1b 
but not Arpc1b-T21A (Fig. 8 A). We used specific siRNAs tar-
geting Aurora A to study the ability of Aurora A to phosphorylate 
T7-Arpc1b in vivo. Selective knockdown of Aurora A in Pak1
/ 
MEFs resulted in inhibition of Arpc1b phosphorylation (Fig. 8 B). 
This suggests Aurora A, in addition to Pak1, is responsible for 
the phosphorylation of Arpc1b. We explored the effect of   
Aurora A knockdown on the interactions of Arpc1b with other 
Arp2/3 complex components in Pak1
/ MEFs. Arpc1b continued 
Figure 8.  Arpc1b: a new Aurora A substrate. 
(A) Kinase assay for GST-Arpc1b and GST- 
Arpc1b T21A proteins in presence of Aurora A.   
Aurora A in the middle panel indicates com-
parable amounts of protein loading. Ponceau- 
stained  blot  shows  equal  quantity  of  GST- 
tagged  proteins  used  for  the  study.  Asterisk 
denotes  the  GST-fused  protein  of  interest. 
(B)  In  vivo  phosphorylation  of  T7-tagged 
Arpc1b  in  the  Pak1
/  MEFs  treated  with 
control or Arpc1b siRNA. (Top to bottom): [
32P]T7- 
Arpc1b, T7-Arpc1b, Aurora A, and vinculin. 
(C)  Western  blot  showing  extent  of  Arpc2   
immunoprecipitated with Arpc1b from Pak1
+/+ 
or Pak1
/ cells after Aurora A knockdown (top   
panel),  effective  Arpc1b  pull-down  (second 
panel), and effective knockdown of Aurora A 
(third panel). Vinculin was used as an internal 
control.  (D)  Western  blot  showing  extent  of 
Arpc1b immunoprecipitated with Arpc2 from 
the Pak1
/ cells after Aurora A knockdown 
(second panel), effective Arpc2 pull-down (top 
panel), and effective knockdown of Aurora A 
(third panel). Vinculin was used as an inter-
nal control. (E) Pak1
/ cells (synchronized in 
G1-S phase) transfected with either control or 
Arpc1b siRNAs were scored for the percent-
age of cells in G2-M phase at the indicated 
time points after release from G1-S arrest using 
FACS analysis; n = 3. (F) Proposed model ex-
plaining the role for threonine 21 phosphoryla-
tion on Arpc1b in Aurora A activation leading 
to  centrosome  amplification.  WB,  Western 
blot; IP, immunoprecipitation; kD, kilodaltons.JCB • VOLUME 190 • NUMBER 1 • 2010   112
in reliable chromosome segregation during mitosis (Gerisch et al., 
2004; Hurst et al., 2004; Igarashi et al., 2005). In conjunction 
with our studies of Arpc1b, these findings open up a new avenue 
of investigation in determining the role of actin-related proteins 
in cellular processes other than actin polymerization, such as   
organization of centrosomal and spindle machineries.
Materials and methods
Cell culture and tissue samples
ZR-75 cells were purchased from American Tissue Culture Collection 
(Manassas,  VA)  and  were  cultured  in  Dulbecco’s  modified  Eagle’s   
medium/F12 (DMEM/F-12) (Mediatech) supplemented with 10% fetal calf 
serum (Hyclone). Human breast cancer samples were from the tumor bank 
at M.D. Anderson Cancer Center (Houston, TX).
Antibodies and reagents
GST-Aurora A, GST-Aurora A kinase-dead (KD), and anti-centrin antibody 
were obtained from Dr. Subrata Sen’s laboratory (M.D. Anderson Cancer 
Center, Houston, TX). (His)6-tagged or GST-fused recombinant full-length   
human Aurora A was purchased from Millipore and Cell Signaling Technol-
ogy, respectively. Antibody against T7-epitope (Novagen); actin, vinculin, 
-tubulin (Sigma-Aldrich); Aurora A, Rac1 (BD; Cell Signaling Technology); 
Pak1, Pak2, phopho-Histone H3 (Ser10), Aurora A, GST, and Arp3 (Cell 
Signaling Technology); Arpc1b (Imgenex; Santa Cruz Biotechnology, Inc.); 
Arpc2, Arp3 (Millipore); Arpc2 and Pak3 (Santa Cruz Biotechnology, Inc.); 
Phospho-Aurora A (Thr288) (Novus Biologicals); and Plk-1, phospho-plk1 
(Thr210) (BioLegend) were used. Purified Arp2/3 complex was purchased 
from  Cytoskeleton,  Inc.  Horseradish  peroxidase  (HRP)–conjugated  anti–
mouse,  anti–goat,  or  anti–rabbit  secondary  antibodies  were  purchased 




/ MEFs (generated in Dr. J. Chernoff’s laboratory) were 
transfected with T7-Arpc1b or T7-Arpc1bT21A or T7-Arpc1b T21A con-
structs using FuGENE 6 transfection reagent (Roche) according to the stan-
dard protocols. Stable clones were selected using G418 selection (1 mg/ml), 
as previously reported (Vadlamudi et al., 2004b).
siRNA transfection
RNA interference against human control siRNA, Arpc1b, Arpc1a, Arp3, 
and Aurora A were purchased from Thermo Fisher Scientific. Cells were 
transfected with 100 nmol/L siRNA (control, Arpc1b, Arpc1a, Aurora A, or 
Arp3 siRNA), 4 µl Oligofectamine (Invitrogen) in 6-well plates according to 
the manufacturer’s protocol. Specific protein knockdown was checked 48 h 
after transfection by Western blot analysis.
GST pull-down assay
In vitro transcription and translation of Arpc1b or Aurora kinases A was 
performed using a T7-TNT kit (Promega) in which 1 µg of cDNA in pcDNA 
3.1 vector was translated in the presence of [
35S]methionine and diluted in 
GST-binding buffer (25 mM Tris-HCl, pH 8.0, 50 mM NaCl, 10% glycerol, 
and 0.1% NP-40). An equal aliquot was used for each GST pull-down. The 
GST pull-down assays were performed by incubating equal amounts of 
GST, GST-tagged full-length proteins, and GST-tagged mutation constructs 
immobilized on glutathione Sepharose beads (GE Healthcare) with in vitro–
translated 
35S-labeled protein. Bound proteins were isolated by incubating 
the mixture for 3 h at 4°C in GST binding buffer. After washing, the proteins 
were eluted in 2× SDS buffer, separated by SDS-PAGE and visualized   
by autoradiography.
Dephosphorylation of Aurora A by phosphatase
Recombinant Aurora A expressed in bacteria was treated with PP1 (New 
England Biolabs, Inc.) using standard protocol (Katayama et al., 2001) 
and incubated with GST or GST-Arpc1b at 30°C for 30 min. The reaction 
was resolved on SDS-PAGE, transferred to nitrocellulose membrane, and 
analyzed using a PhosphorImager.
Aurora kinase assay
The  kinase  reactions  were  performed  using  standard  protocol  (Hirota   
et al., 2003). In brief, 140 ng of Aurora kinase was incubated with either 
1 µg of GST or GST-Arpc1b in kinase buffer (20 mM Hepes, pH 7.5, 10 mM 
MgCl2, 1 mM DTT, and 10 mM KCl) containing 10 µg histone H3 (Active 
To investigate the significance of Arpc1b in Aurora A acti-
vation and cell cycle progression, we again combined cell syn-
chronization with siRNA silencing. Initially, we determined the 
effect of Pak1 depletion on cell cycle progression. Pak1
/ cells 
exhibited delayed entry into the G2/M phase (9 h after double-
thymidine block; unpublished data) compared with the Pak1
+/+ 
MEFs (6 h after double-thymidine block; unpublished data). 
Next, we depleted Arpc1b in the Pak1
/ cells and studied 
the  effects on cell cycle progression. Knockdown of Arpc1b   
in the Pak1
/ MEFs drastically reduced the ability of cells to 
enter the G2/M phase of the cell cycle (Fig. 8 E). Taken together, 
these results reveal a crucial role of Arpc1b in Aurora A acti-
vation and the regulation of cell cycle progression (Fig. 8 F).
Discussion
We identified Arpc1b, a component of the Arp2/3 complex, as a 
novel substrate and activator of Aurora A kinase. Aurora A plays an 
important role in the regulation of spindle formation and mitosis. 
Ectopic overexpression of Aurora A in cultured cells leads to 
polyploidy and centrosome amplification (Zhou et al., 1998;   
Katayama et al., 2003; Stenoien et al., 2003). In addition to its ac-
tivation by genomic amplification, Aurora A is also activated by 
the binding of its protein activators. In this context, our present 
study adds Arpc1b to the list of physiological upstream activators of 
Aurora A. Overexpression of Arpc1b, but not its phosphorylation- 
inactive mutant, bound and activated Aurora A and caused   
centrosomal amplification. This suggests an inherent critical role of 
T21 phosphorylation in executing the newly discovered centro-
somal function of Arpc1b in epithelial (Fig. 5 B) or fibroblast 
cells (Fig. 7 C). We also found that selective knockdown of   
Arpc1b in ZR-75 and Pak1
/ cells delayed the entry of most cells 
into the mitotic phase. Thus, there appears to be a natural role of 
Arpc1b in cell cycle progression from the S to the G2/M phase, 
presumably due to its inherent role in the activation of Aurora A. 
This study also implies the existence of a feedback regulatory 
mechanism between Arpc1b and Aurora A in maintaining spindle 
organization through mitosis.
The existence of Arpc1b in a complex with -tubulin pro-
vides supportive evidence to its role in centrosome duplication 
involving expansion of pericentriolar material. Arpc1b thus serves 
as a cofactor to Aurora A, serving as a substrate as well as an acti-
vator of the kinase involved in the regulation of centrosome du-
plication. However, it is important to remember that in addition to 
Arpc1b, other proteins lacking enzymatic activity, such as co-
factors Tpx2 (Bayliss et al., 2003), Hef1 (Pugacheva and Golemis, 
2005), Ajuba (Hirota et al., 2003), and Bora (Hutterer et al., 2006) 
or even protein phosphatases, may also regulate the initial activa-
tion of Aurora A. Interestingly, LATS2, the downstream substrate 
of Aurora A, has also been reported to interact with and phos-
phorylate the Aurora A cofactor Ajuba, although the functional 
relevance of this phosphorylation has not yet been demonstrated. 
Collectively, the findings reported here and those of previous 
studies suggest that a complex network of Aurora A substrates 
and activators coordinately regulate centrosome maturation and, 
consequently, its function during mitosis. Emerging lines of evi-
dence also point toward a role for actin and actin-related proteins 113 Bidirectional regulation of Arpc1b–Aurora A pathway • Molli et al.
Mouse xenograft studies
For the tumorigenesis studies, total 5 × 10
6 cells of ZR-75/pcDNA or   
ZR-75/Arpc1b clones were bilaterally injected into the mammary fat pads, 
as described previously (Vadlamudi et al., 2004a). Each group had seven 
animals. Tumor growth was monitored for 52 wk, and tumor volume was 
measured. All animal procedures were done in compliance with the Insti-
tute Animal Care and Use Committee and the National Institutes of Health 
Policy on Humane Care and Use of Laboratory Animals.
Soft-agar experiments and sucrose gradient sedimentation
Soft-agar colony growth assays (Mazumdar et al., 2001) and sucrose gra-
dient sedimentation (Humphries et al., 2002) were performed as described 
previously (Mazumdar et al., 2001). In brief, 1 ml of 0.6% DIFCO agar in 
DME supplemented with 10% FBS and insulin was layered onto 60 ×   
15-mm tissue-culture plates. Cells (10,000 cells) were mixed with 1 ml of 
0.36% Bactoagar solution in DME prepared in a similar manner and lay-
ered on top of the 0.6% Bactoagar layer. Plates were incubated at 37°C 
in 5% CO2 for 21 d. For sucrose gradient sedimentation experiments,   
10-ml sucrose gradients (3–30%) were poured in ultra-clear tubes for an 
SW41 rotor (Beckman Coulter). Cell lysates were precleared by centrifuga-
tion for 15 min, 70,000 rpm, 4°C in a TLA100.3 rotor (Beckman Coulter). 
400 µl supernatant or high molecular weight gel filtration size standards 
(GE Healthcare) were layered over each gradient. Samples were centri-
fuged for 15 h at 34,000 rpm, 4°C in an SW41 rotor, and 0.2-ml fractions 
were collected. Samples of each fraction were run on SDS-PAGE gels, blot-
ted, and probed with antibodies to determine the positions of proteins in 
the gradients.
Online supplemental materials
Fig. S1 shows the results from initial exploratory experiments leading to 
this study. Fig. S2 shows the localization of GFP-Arpc1b. Fig. S3 shows the 
verification of the specificity of Arpc1b siRNA. Fig. S4 demonstrates that 
Arpc1a fails to stimulate Aurora A activity. Fig. S5 shows Arpc1b phos-
phorylation by Pak2 and Pak3. Online supplemental material is available 
at http://www.jcb.org/cgi/content/full/jcb.200908050/DC1.
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0.4 µg/ml nocodazole (Sigma-Aldrich) overnight. In case of thymidine, cells 
were  subjected  to  double-thymidine  block.  After  treatments,  cells  were 
washed thrice with PBS and lysed in buffer C (20 mM Hepes, pH 7.5,   
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